MONTREAL and CHARLOTTE, N.C., Nov. 11, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced positive Phase 2 data that show etripamil nasal spray resulted in rapid and ...
MONTREAL and CHARLOTTE, N.C., Sept. 27, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (MIST) today announced that results from a double-blind, randomized, placebo-controlled Phase 2 etripamil ...
When it comes to heart health, many conditions are tricky to diagnose because their symptoms can be similar to others, and atrial fibrillation (AFib) is no exception. That’s a problem, since untreated ...
Midland Daily News on MSN
MyMichigan Health: What to know about atrial fibrillation - signs, risks and treatment options
Lu Chen, M.D., is a cardiologist specializing in electrophysiology with MyMichigan Physicians Group.
Atrial fibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially ...
Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p 0.0001) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results